1
Registered trials
1
Recruiting
1
Unique sponsors
1
Unique IMPs
0
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody
1 substance
Phase II:
1
Phase II
1 trial-
RecruitingUnicancer AcademicZANIDATAMAB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Unicancer | Academic | 1 | Phase II | 1 |
New trials by year
2025
1